Eton Pharmaceuticals, Inc. vs. Exela Pharma Sciences LLC
Explore the PTAB proceeding PGR2020-00086 filed by Eton Pharmaceuticals, Inc. on 2020-09-21. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
PGR2020-00086
Filing Date
2020-09-21
Accorded Filing Date
2020-09-21
Institution Decision Date
2021-04-23
Last Modified Date
—
Proceeding Type
PGR
Termination Date
—
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Eton Pharmaceuticals, Inc.
Represented By
Gabric, Ralph et alPatent Owner / Respondent
Exela Pharma Sciences LLC
Represented By
Whelan, Dorothy et alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34141 | Michael Connor | +1 704-444-1022 |
| 34610 | Guy Gosnell | +1 704-444-1000 |
| 35704 | George Taulbee | +1 704-444-1000 |
| 37505 | Joe Liebeschuetz | +1 650-838-2038 |
| 38114 | Jason Cooper | +1 404--88-1-7000 |
| 38337 | David Teske | +1 404-881-7000 |
| 42365 | Keith Broyles | +1 404-881-7000 |
| 44316 | Susan Sather | +1 650-838-2069 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 10,653,719 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,905,714 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,918,662 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,912,795 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,478,453 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,583,155 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,933,089 B1 | US Continuation / Sibling | View Official Patent → |
Eton Pharmaceuticals Inc. v. Exela Pharma Sciences, LLC
Eton Pharmaceuticals, Inc. v. Exela Pharma Sciences, LLC